NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637113.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $307,000 | – | 127,029 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 45,849 | $27,000 | 1.56% |
| Aisling Capital Management LP | 191,028 | $114,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 357,481 | $214,000 | 0.03% |
| FRAZIER MANAGEMENT LLC | 425,650 | $255,000 | 0.02% |
| Values First Advisors, Inc. | 38,386 | $23,000 | 0.01% |
| Virtu Financial LLC | 209,443 | $125,000 | 0.01% |
| SABBY MANAGEMENT, LLC | 67,051 | $40,000 | 0.01% |
| CCG WEALTH MANAGEMENT, LLC | 10,000 | $6,000 | 0.00% |
| XR Securities LLC | 10,800 | $21,000 | 0.00% |
| HAP Trading, LLC | 23,300 | $34,000 | 0.00% |